Dermatology

This site is intended for healthcare professionals only

Login Register

MD Brand Connect
Webinars
Vaccine Hub
MDTV
Fact Check
Health Dialogues

Medical News & Guidelines
Health news
Fact Check
AYUSH
State News
Medical Education
Industry
MDTV

This site is intended for healthcare professionals only

Login Register

LoginRegister

Home
Medical news & Guidelines
Health news
Fact Check
AYUSH
State News
Medical Education
Industry

Ruchika Sharma

Ruchika Sharma joined Medical Dialogue as an Correspondent for the Business Section in 2019. She covers all the updates in the Pharmaceutical field, Policy, Insurance, Business Healthcare, Medical News, Health News, Pharma News, Healthcare and Investment. She has completed her B.Com from Delhi University and then pursued postgraduation in M.Com. She can be contacted at [email protected] Contact no. 011-43720751

Home

Ruchika Sharma

Articles By : Ruchika Sharma

Lupin gets USFDA tentative nod for Abacavir, Dolutegravir and Lamivudine Tablets for Oral Suspension for HIV-1 infection

Written By Ruchika Sharma24 Jan 2025 12:30 PM IST

Mumbai: Global pharma major Lupin Limited has announced that it has received tentative approval from the United States Food and Drug Administration...

USFDA Closes Inspection at Zydus Ankleshwar Unit-2 With Three Observations

Laurus Labs US arm gets 1 USFDA observation

Written By Ruchika Sharma23 Jan 2025 2:15 PM IST

Andhra Pradesh: Laurus Labs has announced that Laurus Generics Inc., a wholly-owned foreign subsidiary of the company, located in Berkeley...

Zydus Usnoflast gets USFDA Orphan Drug Designation for amyotrophic lateral sclerosis

Written By Ruchika Sharma23 Jan 2025 1:15 PM IST

Ahmedabad: Zydus, a discovery-based, global pharmaceutical company has announced that the U.S. Food and Drug Administration (USFDA) has granted...

Despite SC, NMC orders, rabies immunoglobulin missing in major BMC hospitals

Piramal Critical Care launches Chlorpromazine Hydrochloride for Injection in US

Written By Ruchika Sharma23 Jan 2025 12:15 PM IST

Bethlehem: Piramal Critical Care (PCC), a division of Piramal Pharma Limited has announced the U.S. launch of Chlorpromazine Hydrochloride for...

JnJ wins USFDA approval for subcutaneous Rybrevant Faspro for EGFR-Mutated NSCLC

JnJ Spravato gets USFDA nod as monotherapy for adults with treatment-resistant depression

Written By Ruchika Sharma22 Jan 2025 11:35 AM IST

Titusville: Johnson & Johnson has announced the U.S. Food and Drug Administration (FDA) approval of a supplemental New Drug Application...

$GSK Blenrep combos receive positive EMA Committee opinion in relapsed/refractory multiple myeloma$

GSK gets European Commission nod for expanded use of Jemperli in endometrial cancer

Written By Ruchika Sharma21 Jan 2025 1:30 PM IST

London: GSK plc has announced the European Commission has approved Jemperli (dostarlimab) in combination with chemotherapy...

Cipla Goa facility gets one USFDA observation

Written By Ruchika Sharma21 Jan 2025 11:30 AM IST

Mumbai: Cipla has announced that the United States Food and Drugs Administration (USFDA) has concluded an inspection at the manufacturing...

Aarti Pharmalabs Gets Single Observation in USFDA Inspection at Tarapur Unit

Shalby receives USFDA clearance for knee replacement device

Written By Ruchika Sharma21 Jan 2025 10:00 AM IST

Shalby Advanced Technologies Inc., USA, a step down subsidiary of the Company has received U.S. Food and Drug Administration (FDA) 510(k) Premarket ...

After 40 Years, USFDA Approves Vanda Pharmas Motion Sickness Drug Nereus

AstraZeneca-Daiichi Sankyo Datroway gets USFDA nod for previously treated Metastatic HR Positive, HER2 Negative Breast Cancer

Written By Ruchika Sharma20 Jan 2025 3:01 PM IST

Tokyo: Daichi Sankyo has announced that DATROWAY (datopotamab deruxtecan-dlnk) has been approved in the U.S. for the treatment of adult...

Zydus Lifesciences gets USFDA nod to conduct Phase II(b) clinical trial for Usnoflast for Amyotrophic Lateral Sclerosis

Written By Ruchika Sharma19 Jan 2025 2:45 PM IST

Ahmedabad: Zydus, a discovery-based, global pharmaceutical company has announced that it has received approval from USFDA to conduct Phase...

AstraZeneca to Invest USD 15 Billion in China by 2030

USFDA approves AstraZeneca Calquence, bendamustine, rituximab combo for previously untreated mantle cell lymphoma

Written By Ruchika Sharma18 Jan 2025 1:30 PM IST

Cambridge: AstraZeneca has announced that the Food and Drug Administration (FDA) has approved Calquence (acalabrutinib) in combination with...

Bajaj Healthcare appoints Shreekumar Shankarnarayan Nair as Chief Operating Officer

Bajaj Healthcare gets rights to manufacture, distribute, sell Magnesium L Threonate in India

Written By Ruchika Sharma18 Jan 2025 12:30 PM IST

Mumbai: Bajaj Healthcare Limited has announced that it has received exclusive rights for manufacturing, distribution and sales of the finished...

Powered By: Hocalwire

X

We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok